bionetworkeast.wbresearch.com Event Highlights · pharmaceutical and life science companies. The atmosphere is more relaxed than many large industry conferences, enabling conversations

May 04 - 06, 2015 · Trump International Beach Resort Miami · Miami, FLbionetworkeast.wbresearch.com

Don’t miss our next event - See the details here!

Event Highlights

The Biopharma Industry’s Most Exclusive and Productive Partnering Event

http://www.wbresearch.com/

https://www.linkedin.com/groups/BioNetwork-BioPharma-Industrys-Most-Exclusive-2162723/about%20

Sponsorship for BioNetwork East 2016 Is Now Available!Contact: Rachel Tosi Muser, Sponsorship Director at 646-200-7524 or [email protected]

We launched BioNetwork in 2003 and have been dedicated to supporting partnerships ever since. BioNetwork is the essential platform for business development executives across the pharmaceutical and biotechnology space to come together in an intimate setting and develop relationships that lead to strategic partnerships. BioNetwork is much easier to navigate, find the right contacts, and have private discussions than the huge partnering events. And because only true decision makers (CEOs of biotech firms and VPs of BD from big pharma) attend this gathering, discussions move forward quickly.

Identifying the Next Opportunities for Partnering to Produce Novel Therapies · How can you identify opportunities where there is a high

unmet medical need where you can accelerate an FDA review?

· How can you best identify where synergies lie?

Meeting Today’s Reimbursement Challenges in an Era of Healthcare Reform · How can you integrate health economics and research

outcomes early to show the value of a drug from the payer/provider perspective?

· How can you ensure your comparative effectiveness research methods are effective to ensure reimbursement?

Examining Opportunities, Assessing Risk and Overcoming Challenges When Conducting Business in Emerging Markets · How do you find the right licensing partner in emerging

markets? · What are the best strategies for overcoming issues in

regulatory approval, reimbursement, IP and more?

The 2015 event brought together licensing and business development executives from biopharma to engage in productive partnering meetings and tackle the biggest pain points facing licensing executives:

1

2

3


The Digital and eCommerce Event for Manufacturers and Distributors




Speaker Highlights

Spotlight on the Top Deal Makers of the Last YearR. Christopher Seaton, Senior Vice President, Negotiations, Bayer HealthCare

Jill Jene, Vice President Business Development, Depomed, Inc

Rick Hoyt, Vice President Business Development and Licensing, Mallinckrodt Pharmaceuticals

2014 was a bumper year for mergers and acquisitions with very high profile deals taking place, and the trend continues in 2015. Chris Seaton, Jill Jene and Rick Hoyt were in the trenches for some of the biggest deals of the last year. Panelists revealed what happened in the final hour, how deal structures were altered and what the short- and long-term alliance management strategies look like.

Get Your Firm Noticed and Secure a Partner for Your ProgramJim Hampe, Senior Director, Business Development, Biogen Idec

Jeffrey Warmke, Senior Vice President, External Scientific Affairs, Daiichi Sankyo

Robert Bagdorf, M.D., M.B.A., Vice President, Worldwide Business Development, Pfizer Inc.

All too many smaller firms struggle to get on the radar of the biggest biopharma companies. Jim Hampe, Jeff Warmke and Bob Bagdorf openly discussed what they look for in new partnerships, how to get noticed as an innovator and what goes into de-risking research to prime it for acquisition or investment.

The Anatomy of a Deal: Insight Into the Merck KGaA and Pfizer $2.85B Immuno-oncology AlliancePhilippe Lopes-Fernandes, Senior Vice President & Head of Global Licensing & Business Development, Merck KGaA / Merck Serono

John DeYoung, Vice President, Worldwide Business Development, Pfizer Inc.

In late 2014 Pfizer and Merck KGaA completed the largest transaction for a single asset in the biopharma industry, including the partnership of Merck Serono’s PD-L1 program. Philippe Lopes-Fernandes and John DeYoung kicked off the conference discussing key elements of this complex transaction, how the two parties came to an agreement and plans for ongoing alliance management in one of the hottest therapeutic areas.



“Excellent and productive meeting. Well organized and provided an outstanding forum for partnering discussions with senior level attendees.”

John Adamou, Head, U S Strategic Transactions and Alliance Management, Boehringer Ingelheim



Sponsors of BioNetwork East are instrumental to the licensing and deal making process, from law firms to valuation services to consultancies and more.

Sponsorship is the best way to get your brand in front of the companies you’re targeting. We’ve got the decision-makers, and you have a solution they need – Your next big deal is a handshake away at BioNetwork East.

See the benefits of sponsorship on the following page

Thanks to our sponsors & exhibitors:

Did you know:of b2b marketers find in-person meetings the most effective strategy in selling their products? 77%

Sponsorship



Your Reach As A SponsorAs a sponsor of the event, your brand gets guaranteed exposure before, during, and after the conference. Here’s how:

Your next client.

OUR DATABASE

SOCIAL MEDIA

WEBSITE TRAFFIC

ONSITE EXPERIENCE

MEDIA PARTNERS

8,000 Contacts in Email Database

Speak onsiteto the whole

BioNetwork East audience, demonstrate thought-leadership

Present your brand & solutions

via exhibition booths, roundtables, panels, and demos

Arrange meetingsafter receiving the event’s full

attendee list

1,500 More Contacts

researched by a dedicated

research team

7,601 Visits

5,697 Unique Visitors

17,505 Page views

73.50% New Visits




Testimonials

BioNetwork provides an opportunity that goes beyond a

partnering conference. It allows the attendees to form relationships in a

small and intimate setting.-Kia Motesharei,

Head, Global Licensing & Business Development, Immunology,

EMD Serono / Merck KGaA

Here’s what 2015 participants had to say:

“BioNetwork East provides an excellent forum for small

biotechnology companies to interact 1 on 1 with key decision makers at both leading

pharmaceutical and life science companies. The atmosphere is more relaxed than many large industry conferences, enabling conversations and

presentations that lead to decisions and follow up vs. the normal meet and greet churn.

Was definitely worth my time.

- Evan Lippman, Chief Financial and Business Officer,

Aileron Therapeutics, Inc.

The partnering program allowed me to schedule one-on-one

meetings with representatives of fourteen of the largest pharmaceutical companies throughout the world. I do not think any other conference is able

to provide such a comprehensive series of sessions with similar

types of participants.

- Ben Belinka, CEO, Actinobac Biomed, Inc.



Audience Snapshot

Total Attendees Speakers Companies

69% VP/Director/Head of

7%Senior Manager/Manager

23%C Level/President/Founder

120 42 98

Here’s who you would meet:Seniority

Job Function Industry

48%

Alliance Management

60%

Pharma

17%

Licensing

20%

Bio & Nano-tech

12%

Research

23%

Executive Management

12%

Other

8%

Other



Sample Attendee List Company Job Title

AbbVie Inc Vice President, Search and Evaluation

Acella Pharmaceuticals Chief Executive Officer

AcelrxDirector of Alliance Management And Corporate Development

Achelios Therapeutics President

Akebia Therapeutics Vice President, Business Operations

Alder Biopharmaceuticals, Inc Chief Business Officer

AstraZenecaVice President Of Head of Scientific Partnering and Alliances

Bayer HealthCare Senior Vice President of Negotiations

BIOTECH MEDPARTNERS Managing Partner

BioXcel CorporationDirector Business Development and Alliance Management

Boehringer Ingelheim Pharmaceuticals, Inc.Head of US Strategic Transactions and Alliance Management

Bristol-Myers Squibb Vice President

Epigenetix CEO

Espero Pharma Founder & Chairman

Foley Hoag Partner

Genzyme CorporationVice President, Global Head of Business Development, MS

Horizon PharmaVice President of Business Development and Alliance Management

Merck & Co., Inc. Director, Business Development and Licensing

Merck SeronoHead of Business Development and Licensing, Latin America

Noven Pharmaceuticals, Inc Senior Director, Business Development

Pfenex Inc Director of Business Development

Pfizer Vice President, Worldwide Business Development

RedHill Biopharma CEO

Roche Innovation Center New York Business Development Manager

Sirona Biochem Corporation Chief Business Development Officer

Request the FULL attendee list here


mailto:sponsor%40wbresearch.com?subject=Please%20Send%20The%20Attendee%20List%20For%20BioNetwork%20East


Event Date: May 2-4, 2016

Details: Ask about pricing, speaking opportunities, hosting private events and more.

Don’t Miss Out On The Next Event!

Contact Us About the Next BioNetwork East Event

Sponsorship is Open for 2016

Our Related Events Include:

WEST


mailto:sponsor%40wbresearch.com?subject=Tell%20Me%20About%20the%20Next%20BioNetwork%20East%20Event


About Worldwide Business Research (WBR)

We develop a forum to discuss the issues your customers/prospects care most about and the solutions and strategies that can help them leapfrog over their biggest challenges.

We’re a research and conference company with over 20 years of experience.

We now deliver over 100 quality networking and content focused conferences across the globe.

What began as a mere 12 conference operation has steadily grown into a well-established and reputable research and conference company with offices in London, New York, Toronto and Singapore.


Documents

bionetworkeast.wbresearch.com Event Highlights · pharmaceutical and life science companies. The atmosphere is more relaxed than many large industry conferences, enabling conversations